MedTrace Logo

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

NCT01348399 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2018-06-20

No results posted yet for this study

Summary

The objective of this study is to evaluate effectiveness and safety of XIENCE PRIME stent in the "real world" daily practice as compared with other drug eluting stents (DESs)

Conditions

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Seung-Jung Park

    lead OTHER

Principal Investigators

  • Seung-Jung Park, MD, PhD · Asan Medical Center

  • Ki Bae Seung, MD, PhD · Seoul St. Mary's Hospital, Catholic University of Korea

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2014-07-31
Completion
2017-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01348399 on ClinicalTrials.gov